DARE Dare Bioscience Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: DARE

Price (delayed)

$0.3112

Market cap

$31.3M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.35

Enterprise value

$21.07M

Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. The company's mission is to identify, develop and bring to market a diverse ...

Highlights
DARE's net income is up by 27% since the previous quarter and by 2.5% year-on-year
DARE's EPS is up by 26% since the previous quarter and by 5% year-on-year
The company's gross profit has surged by 181% QoQ but it has shrunk by 72% YoY
DARE's revenue has soared by 181% QoQ but it has shrunk by 72% YoY
The debt has soared by 187% year-on-year
The equity has plunged by 145% YoY and by 121% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.darebioscience.com
Peers: OMER OMGA

Key stats

What are the main financial stats of DARE
Market
Shares outstanding
100.58M
Market cap
$31.3M
Enterprise value
$21.07M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
9.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.5
Earnings
Revenue
$2.81M
EBIT
-$30.16M
EBITDA
-$30.07M
Free cash flow
-$39.49M
Per share
EPS
-$0.35
Free cash flow per share
-$0.45
Book value per share
-$0.05
Revenue per share
$0.03
TBVPS
$0.24
Balance sheet
Total assets
$21.28M
Total liabilities
$26.33M
Debt
$1.4M
Equity
-$5.05M
Working capital
-$2.94M
Liquidity
Debt to equity
-0.28
Current ratio
0.86
Quick ratio
0.61
Net debt/EBITDA
0.34
Margins
EBITDA margin
-1,070.9%
Gross margin
100%
Net margin
-1,074.2%
Operating margin
-1,101.9%
Efficiency
Return on assets
-120.8%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-3,761.8%
Return on sales
-1,074.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

DARE stock price

How has the Dare Bioscience stock price performed over time
Intraday
0.39%
1 week
0.39%
1 month
-35.37%
1 year
-68.36%
YTD
0.71%
QTD
-36.52%

Financial performance

How have Dare Bioscience's revenue and profit performed over time
Revenue
$2.81M
Gross profit
$2.81M
Operating income
-$30.94M
Net income
-$30.16M
Gross margin
100%
Net margin
-1,074.2%
The company's gross profit has surged by 181% QoQ but it has shrunk by 72% YoY
DARE's revenue has soared by 181% QoQ but it has shrunk by 72% YoY
The operating margin has soared by 74% from the previous quarter
The net margin has soared by 74% since the previous quarter

Growth

What is Dare Bioscience's growth rate over time

Valuation

What is Dare Bioscience stock price valuation
P/E
N/A
P/B
N/A
P/S
9.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.5
DARE's EPS is up by 26% since the previous quarter and by 5% year-on-year
The equity has plunged by 145% YoY and by 121% from the previous quarter
DARE's revenue has soared by 181% QoQ but it has shrunk by 72% YoY

Efficiency

How efficient is Dare Bioscience business performance
The ROA has plunged by 90% YoY but it has grown by 10% from the previous quarter
DARE's return on sales has surged by 74% since the previous quarter

Dividends

What is DARE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DARE.

Financial health

How did Dare Bioscience financials performed over time
The total assets is 19% less than the total liabilities
The total assets has plunged by 51% YoY and by 15% from the previous quarter
The company's quick ratio fell by 47% YoY and by 4.7% QoQ
The debt is 128% greater than the equity
The debt has soared by 187% year-on-year
The equity has plunged by 145% YoY and by 121% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.